Font Size: a A A
Keyword [Molecular targeted]
Result: 61 - 80 | Page: 4 of 7
61. Correlation Of Apparent Diffusion Coefficients Value From MR Duffusion-weighted Imaging With HER2 Status In Gastric Cancers
62. The Design And Synthesis Of The Tumor-targeted Drug, Bufalin’s Derivatives
63. Research On The Difference Analysis Method Of The Microarray Data In Disease
64. Effect Of TRKs Inhibitors On Biological Behaviors Of Human Glioblastma Cells
65. Roles Of SNAI2—E-cadherin Axis In The Regulation Of Invasion And Metastasis Of Glioma Cells By LRIG1
66. Neoadjuvant Therapy Of Molecular Targeted Drug On Patients With Advanced Renal Cell Carcinoma
67. The Effect Of NVP-BKM120 Combined With NVP-RAD001 On Triple-negative Breast Cancer Stem Cells
68. The Curative Effects Of EGFR-TKIs In Different EGFR Mutation Genotypes And Its Relationship With Expression Of AEG-1 In Advanced Lung Adenocarcinoma
69. Systematic Evaluation Of The Safety And Efficacy Of Gemcitabine Combined With Molecular Targeted Agents And Platinum Based Drugs In The Treatment Of Patients With Advanced Pancreatic Cancer
70. A Gene-ADR Network Based Pharmacovigilance Study Of Small Molecular Targeted Anti-tumor Drugs
71. The Experimental Study Of Pancreatic Cancer Using Molecular Probe Targeting MUC5AC
72. The Clinical Observation Of First-Line Sunitinib In 56 Patients With Gastrointestinal Stromal Tumors
73. Radiotherapy Combined With Iressa For Patients With Locally Advanced Non-small Cell Lung Cancer Who Couldn't Receive Surgery And Concurrent Chemoradiotherapy:the Preliminary Results Of A Phase ? Clinical Trial
74. Application And Prospects Of Molecular Targeted Therapy For Colorectal Cancer
75. Outcome Of Molecular Targeted Agents Plus Chemotherapy For Second-line Therapy Of Metastatic Colorectal Cancer: A Meta-analysis Of Randomized Trials
76. Construction And Evaluation Of The Effectiveness Of Nanoparticles With Molecular Targeted Drugs And Radioiodine Co-loaded For Anaplastic Thyroid Cancer Cells
77. Tumor Heterogeneity Of Epithelial Ovarian Cancer And Advances Of Molecular Targeted Therapy
78. Apatinib With Gefitinib Or Icotinib For Advanced Non-small Cell Lung Cancer Patients With Acquired Resistance To First-generation EGFR-TKIs
79. Inhibitory Mechanism On HBV And ALK And Gene Network Analysis In NSCLC
80. The Role Of Mammalian Rapamycin Target Protein MTOR In The Treatment Of Bladder Cancer And Its Research Progress
  <<First  <Prev  Next>  Last>>  Jump to